KCTD7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.679000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.824000E-01
Normal-vs-Stage2
3.552600E-01
Normal-vs-Stage3
2.231600E-01
Normal-vs-Stage4
7.716600E-01
Stage1-vs-Stage2
1.724420E-01
Stage1-vs-Stage3
4.420300E-02
Stage1-vs-Stage4
4.816600E-01
Stage2-vs-Stage3
1.424370E-01
Stage2-vs-Stage4
2.861800E-02
Stage3-vs-Stage4
4.143600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.758600E-01
Normal-vs-AfricanAmerican
3.783000E-01
Normal-vs-Asian
3.776100E-02
Caucasian-vs-AfricanAmerican
9.483600E-01
Caucasian-vs-Asian
7.590200E-02
AfricanAmerican-vs-Asian
2.818000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.788400E-01
Normal-vs-Female
3.586800E-01
Male-vs-Female
6.154800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.925800E-01
Normal-vs-Age(41-60Yrs)
4.587800E-01
Normal-vs-Age(61-80Yrs)
3.359400E-01
Normal-vs-Age(81-100Yrs)
2.911800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.118600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.406800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.275800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.338000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.265700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.884200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.480000E-02
Normal-vs-Daily Drinker
3.076600E-01
Normal-vs-Weekly Drinker
1.537160E-01
Normal-vs-Occasional Drinker
3.652800E-01
Normal-vs-Social Drinker
2.136200E-01
Non Drinker-vs-Daily Drinker
6.831000E-01
Non Drinker-vs-Weekly Drinker
4.492000E-01
Non Drinker-vs-Occasional Drinker
7.247000E-01
Non Drinker-vs-Social Drinker
1.719620E-01
Daily Drinker-vs-Weekly Drinker
2.433600E-01
Daily Drinker-vs-Occasional Drinker
4.256400E-01
Daily Drinker-vs-Social Drinker
6.799600E-02
Weekly Drinker-vs-Occasional Drinker
6.520000E-01
Weekly Drinker-vs-Social Drinker
6.160800E-01
Occasional Drinker-vs-Social Drinker
2.942400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.557200E-01
Normal-vs-Grade 2
7.757000E-01
Normal-vs-Grade 3
7.984400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.806200E-01
Grade 1-vs-Grade 3
8.256200E-01
Grade 1-vs-Grade 4
5.557200E-01
Grade 2-vs-Grade 3
6.721600E-01
Grade 2-vs-Grade 4
7.757000E-01
Grade 3-vs-Grade 4
7.984400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.757500E-02
Normal-vs-NonDiabetic
3.569800E-01
Diabetic-vs-NonDiabetic
8.519800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.457000E-01
Normal-vs-NoPancreatitis
3.509000E-01
Pancreatitis-vs-NoPancreatitis
3.086800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.968100E-02
Normal-vs-N1
3.570400E-01
N0-vs-N1
5.810800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.948600E-01
Normal-vs-TP53-NonMutant
1.116790E-01
TP53-Mutant-vs-TP53-NonMutant
1.169160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
